Quantum Pharmaceuticals is developing small molecule PFKFB3 inhibitors for the treatment of solid tumors, including colon cancer, pancreatic cancer, TNBC and HCC (Presentation, Quantum Pharmaceuticals, JUN 2, 2014, View Source; width="640" height="480" [SID:1234500571]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!